130 related articles for article (PubMed ID: 36326326)
21. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
Lax S
Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
[TBL] [Abstract][Full Text] [Related]
22. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
Raffone A; Catena U; Travaglino A; Masciullo V; Spadola S; Della Corte L; Piermattei A; Insabato L; Zannoni GF; Scambia G; Zullo F; Bifulco G; Fanfani F; Di Spiezio Sardo A
Gynecol Oncol; 2021 Jun; 161(3):795-801. PubMed ID: 33812697
[TBL] [Abstract][Full Text] [Related]
23. Prognostic aspects on endometrial hyperplasia and neoplasia.
Sivridis E; Giatromanolaki A
Virchows Arch; 2001 Aug; 439(2):118-26. PubMed ID: 11561751
[TBL] [Abstract][Full Text] [Related]
24. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
25. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
Cameron RI; Maxwell P; Jenkins D; McCluggage WG
Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
[TBL] [Abstract][Full Text] [Related]
27. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
[TBL] [Abstract][Full Text] [Related]
28. [Endometrial hyperplasia predicts a better prognosis in endometrial carcinoma].
Mihailovici MS; Teleman S
Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):367-70. PubMed ID: 14755942
[TBL] [Abstract][Full Text] [Related]
29. Management of endometrial precancers.
Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL;
Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535
[TBL] [Abstract][Full Text] [Related]
30. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
[TBL] [Abstract][Full Text] [Related]
31. Updates on Conservative Management of Endometrial Cancer.
Corzo C; Barrientos Santillan N; Westin SN; Ramirez PT
J Minim Invasive Gynecol; 2018 Feb; 25(2):308-313. PubMed ID: 28782618
[TBL] [Abstract][Full Text] [Related]
32. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions.
Sullivan MW; Philp L; Kanbergs AN; Safdar N; Oliva E; Bregar A; Del Carmen MG; Eisenhauer EL; Goodman A; Muto M; Sisodia RC; Growdon WB
Gynecol Oncol; 2021 Sep; 162(3):613-618. PubMed ID: 34247769
[TBL] [Abstract][Full Text] [Related]
33. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
Park CK; Yoon G; Cho YA; Kim HS
Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
[TBL] [Abstract][Full Text] [Related]
35. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
36. Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System.
Travaglino A; Raffone A; Saccone G; Mascolo M; Guida M; Mollo A; Insabato L; Zullo F
Am J Clin Pathol; 2020 Jan; 153(1):40-48. PubMed ID: 31433834
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
Younes SF; Aiad H; Kandil M; El Kalashy FS
Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
[TBL] [Abstract][Full Text] [Related]
38. ARID1A Regulates Progesterone Receptor Expression in Early Endometrial Endometrioid Carcinoma Pathogenesis.
Asaka S; Liu Y; Yu ZC; Rahmanto YS; Ono M; Asaka R; Miyamoto T; Yen TT; Ayhan A; Wang TL; Shih IM
Mod Pathol; 2023 Feb; 36(2):100045. PubMed ID: 36853791
[TBL] [Abstract][Full Text] [Related]
39. Theories of endometrial carcinogenesis: a multidisciplinary approach.
Sherman ME
Mod Pathol; 2000 Mar; 13(3):295-308. PubMed ID: 10757340
[TBL] [Abstract][Full Text] [Related]
40. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
